NKX3A Primary Antibody

Item Information
Catalog #Size/ConcentrationPrice
Specification
AliasesNKX3; BAPX2; NKX3A; NKX3.1; NKX3-1
ProductOrderN
Clone#4H4
Entrez GenelD4824
FormulationAscitic fluid containing 0.03% sodium azide.
HostMouse
IsotypeIgG2b
ImmunogenPurified recombinant fragment of human NKX3A expressed in E. Coli.
MW26.3kDa
Shipping InformationThis product will ship in a box containing blue ice at a temperature of 4°C. Learn More
Species ReactivityHuman
Application
ELISA1/10000
IHC_P(Immunohistochemistry)1/200 - 1/1000
FCM (Flow Cytometry)1/200 - 1/400
WB (Western Blot)1/500 - 1/2000
Sequence
full(1-234)
Catalog#: 30027
Inquire
Contact us to order
Images
Western Blot
Figure 1: Western blot analysis using NKX3A mouse mAb against LNCaP (1) cell lysate.
Figure 1: Western blot analysis using NKX3A mouse mAb against LNCaP (1) cell lysate.
Immunohistochemical analysis
Figure 2: Immunohistochemical analysis of paraffin-embedded human prostata tissues (A, B) using anti-NKX3A antibody with DAB staining.
Figure 2: Immunohistochemical analysis of paraffin-embedded human prostata tissues (A, B) using anti-NKX3A antibody with DAB staining.
Immunohistochemical analysis
Figure 3: Immunohistochemical analysis of paraffin-embedded human Liver tissues using NKX3A mAb
Figure 3: Immunohistochemical analysis of paraffin-embedded human Liver tissues using NKX3A mAb
Flow cytometric
Figure 4: Flow cytometric analysis of PC-3 cells using anti-NKX3A mAb (green) and negative control (purple).
Figure 4: Flow cytometric analysis of PC-3 cells using anti-NKX3A mAb (green) and negative control (purple).
Product Overview
Description

Nkx3.1 is a transcription factor that may play an important role in regulating proliferation of glandular epithelium and in the formation of ducts in the prostate. It has been thought to be one of the target genes of the 8p21 loss of heterozygosity, common in prostate cancer. But neither disruption of the coding region of the gene, nor mutations have been found in prostate cancer.

References (references)
References (references)1. Exp Mol Med. 2006 Dec 31;38(6):625-33.
2. Exp Biol Med (Maywood). 2008 Mar;233(3):297-309.
3.Mol Biol Rep. 2010 Mar;37(3):1505-12.